Fig. 4: Univariate Cox regression analysis of prognosis factors. | Blood Cancer Journal

Fig. 4: Univariate Cox regression analysis of prognosis factors.

From: Penpulimab combined with rituximab, high-dose methotrexate, and cytarabine (Pen-RMA) in newly diagnosed primary central nervous system lymphoma (PCNSL): a phase 2 trial

Fig. 4: Univariate Cox regression analysis of prognosis factors.

Progression-free survival (a) and overall survival (b). IELSG international extranodal lymphoma study group, ECOG eastern cooperative oncology group, COO cell of origin, LDH lactate dehydrogenase, CSF cerebrospinal fluid, ctDNA circulating-tumor DNA, EOT end of treatment.

Back to article page